The consequences of ineffective regulation of dietary supplements

Archives of Internal Medicine

Volumn 172, Issue 13, 2012, Pages 1035-1036

  Marcus, Donald M ^a   Grollman, Arthur P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; EPHEDRA EXTRACT; MINERAL; VITAMIN;

CONSUMER; DECEPTION; DIET SUPPLEMENTATION; DRUG FATALITY; DRUG MANUFACTURE; EPHEDRA; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; FUNDING; HEALTH EDUCATION; HERBAL MEDICINE; HUMAN; MARKETING; MEDICAL SOCIETY; NOTE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PRODUCT SAFETY; SEIZURE; UNITED STATES; WEIGHT REDUCTION;

BLOOD PRESSURE; DIETARY SUPPLEMENTS; HEART RATE; HUMANS; MALEIC ANHYDRIDES; SAFETY-BASED DRUG WITHDRAWALS;

EID: 84863691678     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.2687     Document Type: Note

References (14)

1. 103rd US Congress. Dietary Supplement Health and Education Act of 1994. http://ods.od.nih.gov/about/dshea-wording.aspx. Accessed May 15, 2012.
2. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;(18):1-14.
3. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854-859.
4. US Government Accountability Office. Dietary supplements: FDA should take further actions to improve oversight and consumer understanding. http://www.gao.gov/products/GAO-09-250. Accessed May 15, 2012.
5. Cohen PA. DMAA as a dietary supplement ingredient [published online May 7, 2012, corrected May 14, 2012.]. Arch Intern Med. 2012;172(13):1038-1039.
6. Ashar BH, Miller RG, Pichard CP, Levine R, Wright SM. Patients' understanding of the regulation of dietary supplements. J Community Health. 2008;33(1):22-30. (Pubitemid 350275953)
7. US Government Accountability Office. Herbal dietary supplements: examples of deceptive or questionable marketing practices and potentially dangerous advice. http://www.gao.gov/products/GAO-10-662T. Accessed May 15, 2012.
8. Hamburg MA. Letter to manufacturers of dietary supplements. http://www.fda.gov/downloads/Drug/ResourcesForYou/Consumers/ BuyingUsingMedicinesSafely/MedicationHealthFraud/ucm236985.pdf. December 15, 2010. Accessed January, 2012.
9. Food and Drug Administration. Draft Guidance for Industry: dietary supplements: new dietary ingredient notifications and related issues, July 2011. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/DietarySupplements/ucm257563.htm. Accessed May 18, 2012.
10. European Union. Laying down community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Medicines agency: regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31 March, 2004. http://eur-lex.europa. eu/LexUriServ/LexUriServ.do?uri= OJ: L: 2004: 136: 0085: 0090: en. pdf. Accessed May 4, 2011.
11. Medical Economics. PDR for Herbal Medicines. Tampa, FL: Thomson Publishing Group; 1998.
12. Staff PDR. Physicians' Desk Reference. Montvale, NJ: PDR Network; 2011.
13. Ashar BH, Rice TN, Sisson SD. Physicians' understanding of the regulation of dietary supplements. Arch Intern Med. 2007;167(9):966-969. (Pubitemid 46762760)
14. Marcus DM, McCullough L. An evaluation of the evidence in "evidence-based" integrative medicine programs. Acad Med. 2009;84(9):1229-1234.